Blanket Purchase Agreement 36F79721D0213-36E79723A0012
Award Date
2/7/23
Last Date to Order
2/6/26
Federal Agency
National Acquisition Center
Awardee
Hikma Pharmaceuticals USA Inc.
Ultimate Awardee
Hikma Specialty USA Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price Award Fee
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
Hikma Pharmaceuticals USA Inc., a foreign-owned, for-profit pharmaceutical manufacturer, holds a $216 million Federal Supply Schedule contract (FSS-61-IB) with the Department of Veterans Affairs (VA) for the procurement of pharmaceuticals and drugs. This multiple-award, unrestricted Indefinite Delivery Vehicle (IDV) enables Hikma to provide a wide range of pharmaceutical products, including injectable solutions, tablets, and specialized medications, to military treatment facilities, VA...
The Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract (IDC) worth up to $42,907,335.98 to Hikma Pharmaceuticals USA Inc., formerly known as West-Ward Pharmaceuticals. As a large, foreign-owned, for-profit manufacturer of goods, Hikma will serve as the prime contractor to supply a wide range of generic injectable and non-injectable pharmaceutical products and medical supplies to support the healthcare needs of military personnel, veterans, and their...
The U.S. Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) worth up to $2,500,000 to Amneal Pharmaceuticals of New York, LLC, a for-profit limited liability company that manufactures pharmaceutical products. The BPA is for the provision of the generic drug sodium oxybate, which is used to treat narcolepsy. Amneal Pharmaceuticals holds several indefinite delivery vehicle (IDV) contracts with federal agencies, including a 5-year, $1,700,000 Federal Supply...
The key products and services being delivered under this federal contract Indefinite Delivery Vehicle (IDV) award are pharmaceutical and hematology-related products. The contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 (VA VISN 12) to the prime contractor, Hikma Specialty USA Inc. This is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, with a potential contract value...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs National Acquisition Center to Idorsia Pharmaceuticals US Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals and related products. The $3.1 million single-award contract establishes an Indefinite Delivery Vehicle (IDV) for the procurement of orexin inhibitors, a class of sleep-regulating medications, over a one-year base period with four option years. This BPA aims to ensure the availability of...
The government has awarded a Blanket Purchase Agreement (BPA) to Nephron Sterile Compounding Center LLC, a woman-owned limited liability company, to provide pharmaceutical products and supplies to the Defense Health Agency (DHA). The BPA has a ceiling value of $4,000,000 and a period of performance through March 31, 2025. Under this BPA, Nephron has received two specific task orders to date. The first is a $20,625 firm fixed price award for various injectable pharmaceutical products including...
The National Acquisition Center, a civilian agency within the U.S. Department of Veterans Affairs (VA), awarded a $5,000,000 Blanket Purchase Agreement (BPA) to Harmony Biosciences LLC for the procurement of WAKIX (pitolisant) tablets. WAKIX is a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The BPA, awarded under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), has a base year and four one-year option periods, with a...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Nobelpharma America, LLC, a foreign-owned, self-certified small disadvantaged business. The single-award BPA, valued at up to $4.5 million, is for the delivery of the medication HYFTOR through June 2026. HYFTOR is likely used to treat conditions like post-traumatic stress disorder and chronic pain among veterans. In addition to this BPA, Nobelpharma America, LLC...
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian agency within the U.S. federal government, to Takeda Pharmaceuticals America Inc., a foreign-owned, for-profit manufacturer of specialized pharmaceutical products. The BPA, valued at $131,039,520.00, is a single-award contract that falls under the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule. It enables the procurement of various critical medications such as CINRYZE,...
This Blanket Purchase Agreement (BPA) contract was awarded by the National Acquisition Center, a civilian federal agency, to Merz Pharmaceuticals, LLC, a for-profit foreign-owned organization. The BPA is established under the GSA Federal Supply Schedule 61-IB for Pharmaceuticals and Drugs, with a ceiling value of $12,057,300.00 and a period of performance running through March 12, 2026. The purpose of this BPA is to provide the agency with the pharmaceutical products Ampyra and Inbrijia. No...